JPMorgan Chase – JPMorgan Chase – Activision Blizzard, Inc. (NASDAQ:ATVI) Increases Dividend to $0.47 Per Share | Fintech Zoom
JPMorgan Chase – Activision Blizzard, Inc. (NASDAQ:ATVI) Increases Dividend to $0.47 Per Share
Activision Blizzard, Inc. (NASDAQ:ATVI) announced an annual dividend on Thursday, February 4th, Zacks reports. Investors of record on Thursday, April 15th will be given a dividend of 0.47 per share on Thursday, May 6th. This represents a dividend yield of 0.46%. The ex-dividend date of this dividend is Wednesday, April 14th. This is a boost from Activision Blizzard’s previous annual dividend of $0.41.
Activision Blizzard has raised its dividend by 36.7% over the last three years.
ATVI stock opened at $101.61 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 4.12 and a current ratio of 4.12. The stock has a market cap of $78.53 billion, a P/E ratio of 35.53, a P/E/G ratio of 1.72 and a beta of 0.71. The firm has a 50 day simple moving average of $91.39 and a 200 day simple moving average of $83.14. Activision Blizzard has a 52 week low of $50.51 and a 52 week high of $104.23.
Activision Blizzard (NASDAQ:ATVI) last posted its quarterly earnings results on Wednesday, February 3rd. The company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.18 by $0.03. Activision Blizzard had a net margin of 28.90% and a return on equity of 19.07%. During the same quarter in the previous year, the company earned $1.23 earnings per share. Sell-side analysts predict that Activision Blizzard will post 3.22 EPS for the current year.
In related news, Director Casey Wasserman sold 10,000 shares of the business’s stock in a transaction on Friday, December 4th. The shares were sold at an average price of $80.75, for a total transaction of $807,500.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 1.13% of the company’s stock.
Several research firms recently commented on ATVI. MKM Partners raised their price target on shares of Activision Blizzard from $100.00 to $105.00 in a report on Thursday, January 14th. JPMorgan Chase & Co. lifted their target price on shares of Activision Blizzard from $101.00 to $115.00 and gave the company an “overweight” rating in a research note on Friday. Credit Suisse Group lifted their target price on shares of Activision Blizzard from $96.00 to $106.00 and gave the company an “outperform” rating in a research note on Monday, February 1st. Morgan Stanley lifted their target price on shares of Activision Blizzard from $108.00 to $115.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Stifel Nicolaus lifted their target price on shares of Activision Blizzard from $97.00 to $102.00 and gave the company a “buy” rating in a research note on Wednesday, October 21st. Four equities research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $98.00.
Activision Blizzard Company Profile
Activision Blizzard, Inc, together with its subsidiaries, develops and distributes content and services on video game consoles, personal computers (PC), and mobile devices in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Activision Publishing, Inc; Blizzard Entertainment, Inc; and King Digital Entertainment.
Read More: Is the QQQ ETF safe?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle
October 2, 2020, may not rank as one of those “where were you when” moments. But when news broke that the President of the United States and the First Lady tested positive for the novel coronavirus, there was certainly a sense that we were living through a historical moment (as if we already were not).
Over the following days, several biotech and pharmaceutical companies took the headlines. However, these weren’t the vaccine stocks that investors have committed to memory. These were companies that are leading the race for antiviral therapeutics.
And with a very high profile proof of concept, therapeutics may have had their moment. It’s far too early to say whether these drugs truly carry the answer. But from the outset of the pandemic, there has been a feeling that therapeutics may carry the ultimate solution to neutralizing the most severe effects of the novel coronavirus.
As you might expect, there is no shortage of companies in the therapeutic discussion. In this special presentation, we’re highlighting seven companies that you should be paying close attention to. If therapeutics nudge ahead of a vaccine, these stocks are likely to make strong upward moves.
View the “7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle”.
JPMorgan Chase – Activision Blizzard, Inc. (NASDAQ:ATVI) Increases Dividend to $0.47 Per Share
JPMorgan Chase – JPMorgan Chase – Activision Blizzard, Inc. (NASDAQ:ATVI) Increases Dividend to $0.47 Per Share | Fintech Zoom
Tags: JPMorgan Chase
